Rare diseases
Investigational molecules
Locations
Recruiting trials first
8 clinical trials in this condition
Germany
Denmark
SpainGermanyIn short
Gallbladder cancer is a rare but serious disease that often goes unnoticed until it has spread beyond the gallbladder. Treatment success depends heavily on how early the cancer is found, but many patients receive their diagnosis only when the disease has already advanced. Understanding the available treatment approaches, both standard and experimental, can help patients and families navigate this challenging journey.
Surgery offers the best chance for curing gallbladder cancer, but only when the cancer can be completely removed. The type of surgery depends on how far the cancer has spread. For very early cancer that is discovered by chance during gallbladder removal for other reasons such as gallstones, a simple cholecystectomy (removal of the gallbladder) may be enough. This procedure can sometimes be done using small incisions and a camera, which is called laparoscopic surgery.
However, most gallbladder cancers require a more extensive operation called an extended cholecystectomy or radical cholecystectomy. During this surgery, doctors remove not only the gallbladder but also a portion of the liver tissue next to it and all nearby lymph nodes. Lymph nodes are small bean-shaped structures that are part of the body's immune system and can harbor cancer cells. In some cases, surgeons may need to remove larger sections of the liver, part of the pancreas, the bile duct (the tube that carries digestive fluid from the liver to the intestine), or additional lymph nodes depending on where the cancer has spread.
Not all patients are candidates for surgery aimed at curing the cancer. When cancer has spread too far to be removed completely, doctors may recommend palliative surgery. This type of surgery does not aim to cure the disease but instead helps relieve symptoms. For example, if the cancer blocks the bile ducts, causing yellowing of the skin and eyes (a condition called jaundice), surgeons can insert a small tube called a stent to keep the duct open or create a new pathway for bile to flow around the blockage. These procedures can significantly improve comfort and quality of life.
Chemotherapy refers to medications that kill cancer cells or stop them from growing. These drugs travel through the bloodstream to reach cancer cells throughout the body, making chemotherapy useful when cancer has spread beyond the gallbladder or when there is a risk that microscopic cancer cells remain after surgery.
Chemotherapy may be given in several situations. After surgery, it is called adjuvant chemotherapy and aims to destroy any remaining cancer cells that were too small to see or remove, reducing the chance the cancer will come back. When surgery is not possible because the cancer has spread too widely, chemotherapy serves as the main treatment to slow cancer growth and control symptoms. The most commonly used chemotherapy combination for advanced gallbladder cancer is gemcitabine and cisplatin, which has been shown to help patients live longer compared to gemcitabine alone.
Chemotherapy is usually given in cycles, with treatment periods followed by rest periods to allow the body to recover. Most chemotherapy drugs for gallbladder cancer are given through a vein (intravenously) at a hospital or clinic. The treatment schedule and duration depend on the stage of cancer, the specific drugs used, and how well the patient tolerates the treatment.
Like all cancer treatments, chemotherapy can cause side effects. Common ones include nausea and vomiting, loss of appetite, fatigue, hair loss, increased risk of infection due to low white blood cell counts, and mouth sores. These effects happen because chemotherapy affects both cancer cells and some normal cells that divide rapidly. Most side effects are temporary and improve after treatment ends, and there are many supportive medications available to help manage them.
Radiation therapy uses high-energy beams, similar to X-rays but much stronger, to kill cancer cells. For gallbladder cancer, radiation may be used after surgery to destroy any cancer cells left behind in the area where the tumor was removed. This is particularly helpful when surgeons cannot remove the cancer completely or when there is concern that microscopic cancer remains at the edges of the removed tissue.
Radiation therapy can also provide relief for patients with advanced cancer. When tumors grow large enough to press on nerves or block important structures like bile ducts, radiation can shrink these tumors and ease pain or jaundice. This palliative radiation does not cure the cancer but can significantly improve comfort and daily functioning.
Treatment is typically given five days a week for several weeks. Each session lasts only a few minutes and is painless, though patients must lie still while the radiation machine delivers the treatment. Side effects of radiation to the abdomen may include skin irritation in the treated area, fatigue, nausea, and diarrhea. These effects usually develop gradually and improve within weeks after treatment ends.
Clinical trials are research studies that test new treatments or new ways of using existing treatments. They follow strict scientific and ethical guidelines to ensure patient safety. Trials are conducted in phases, each designed to answer specific questions. Phase I trials test whether a new treatment is safe and determine the best dose. Phase II trials evaluate whether the treatment works against a specific type of cancer. Phase III trials compare the new treatment with the current standard treatment to see which works better.
Participating in a clinical trial may give patients access to promising new treatments before they become widely available. However, trials also involve uncertainties, as researchers do not yet know all the effects of experimental treatments. Patients considering a trial should discuss the potential benefits and risks thoroughly with their doctors.
Targeted therapies are drugs designed to attack specific molecules or pathways that cancer cells need to grow and survive. Unlike chemotherapy, which affects all rapidly dividing cells, targeted therapies aim more precisely at cancer cells, potentially causing fewer side effects. For gallbladder cancer, researchers have identified several molecular targets that may be vulnerable to these new drugs.
Recent advances in understanding the genetic and molecular characteristics of gallbladder cancer have revealed that some tumors have specific changes in their DNA or proteins that can be targeted with drugs. These discoveries have opened new avenues for treatment, especially for patients whose cancer has spread and does not respond well to standard chemotherapy. Testing tumor tissue for these molecular changes helps doctors identify which patients might benefit from targeted therapies.
Clinical trials are testing various targeted drugs for gallbladder cancer. These drugs work by blocking signals that tell cancer cells to grow, cutting off the blood supply that feeds tumors, or interfering with proteins that help cancer cells survive. While some targeted therapies are still in early testing phases to establish safety, others are in later phases comparing their effectiveness to standard treatments. Results from early studies have shown promise, with some patients experiencing tumor shrinkage or stabilization of their disease.
Immunotherapy represents an exciting area of cancer research. These treatments work by helping the patient's own immune system recognize and attack cancer cells. Cancer cells often have ways of hiding from the immune system or turning off immune responses, and immunotherapy drugs can block these escape mechanisms.
For gallbladder cancer, immunotherapy is being tested in clinical trials, often in combination with chemotherapy. Some studies are evaluating drugs called checkpoint inhibitors, which remove the "brakes" that cancer cells put on immune cells, allowing the immune system to mount a stronger attack against the tumor. Early results have been encouraging in some patients, particularly those whose tumors have certain molecular characteristics.
Immunotherapy may be given alone or combined with other treatments. It is typically administered through an intravenous infusion every few weeks. Side effects differ from those of chemotherapy and can include fatigue, skin rashes, diarrhea, and inflammation of various organs. These effects occur because the activated immune system sometimes attacks normal tissues along with cancer cells. Most side effects can be managed with medications, but they require close monitoring by the healthcare team.
Researchers are exploring whether combining different types of treatment produces better results than single treatments. For example, some trials are testing chemotherapy together with targeted therapy or immunotherapy. The rationale is that these treatments attack cancer through different mechanisms, potentially making it harder for cancer cells to survive and develop resistance.
Clinical trials for gallbladder cancer are conducted at major cancer centers in various locations, including the United States, Europe, and other parts of the world. Eligibility for these trials depends on factors such as the stage of cancer, previous treatments received, overall health status, and specific characteristics of the tumor. Patients interested in clinical trials should ask their oncologist about available options and whether they might be good candidates.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
